Good Life Advisors LLC Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Good Life Advisors LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,636 shares of the healthcare conglomerate’s stock after selling 22 shares during the period. Good Life Advisors LLC’s holdings in UnitedHealth Group were worth $862,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Richelieu Gestion SA bought a new stake in UnitedHealth Group during the fourth quarter worth about $26,000. Robbins Farley purchased a new position in shares of UnitedHealth Group in the third quarter worth about $25,000. CGC Financial Services LLC increased its holdings in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares during the period. NewSquare Capital LLC increased its holdings in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares during the period. Finally, Strategic Investment Solutions Inc. IL purchased a new position in UnitedHealth Group during the 1st quarter valued at about $35,000. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently commented on UNH. Truist Financial reissued a “buy” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research report on Thursday, November 30th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. HSBC reissued a “reduce” rating and set a $480.00 price target (down from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. Stephens restated an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Finally, Piper Sandler reduced their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research note on Wednesday, January 17th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $579.33.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 0.3 %

NYSE UNH traded up $1.60 on Thursday, hitting $494.70. The stock had a trading volume of 3,816,496 shares, compared to its average volume of 4,097,565. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $554.70. The business’s fifty day moving average price is $503.10 and its 200 day moving average price is $518.61. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The stock has a market cap of $456.08 billion, a price-to-earnings ratio of 20.70, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. The business had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company’s quarterly revenue was up 14.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $5.34 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.